(Q34057571)

30 July 2017

1 reference

title

Drug-induced liver disease. (English)

1 reference

30 July 2017

J H Lewis

1

1 reference

30 July 2017

publication date

1 September 2000

1 reference

Medical Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

84

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

1275-311, x

1 reference

Cholestatic hepatic injury related to warfarin exposure

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

The natural history of histologically proved drug induced liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatocellular injury in a patient receiving rosiglitazone. A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Serum transaminase elevations as indicators of hepatic injury following the administration of drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Fulminant liver failure associated with flutamide therapy for hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Nefazodone-induced liver failure: report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Jaundice after therapy with chlordiazepoxide hydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Tolcapone and fulminant hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Metformin-induced acute hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Comparative tolerability of the newer fluoroquinolone antibacterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity in drug development: detection, significance and solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Cholestatic jaundice caused by D-penicillamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Reye's syndrome in the United States from 1981 through 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

The lymphocyte transformation test--a debated method for the evaluation of drug allergic hepatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity following desflurane anesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Use and outcome of liver transplantation in acetaminophen-induced acute liver failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Sulfasalazine-Induced Fulminant Hepatitis in Pediatric Crohn's Disease: Report of Two Cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Evaluation of hepatoprotective activity of Cassia fistula leaf extract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Liver reactions to oral low-dose tetracyclines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Losartan-Induced Hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Severe hepatitis in three AIDS patients treated with indinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity related to intracavernous pharmacotherapy with papaverine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Acute hepatitis due to fluoxetine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Tamoxifen-induced transient multifocal hepatic fatty infiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Effect of rifampicin on liver function in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Icteric toxic hepatitis associated with riluzole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Frequency of flutamide induced hepatotoxicity in patients with prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Labetalol hepatotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity associated with sustained-release niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Causality assessment of drug-induced liver injury. Hepatology Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Vanishing bile duct syndrome in drug-induced liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Valproate-associated hepatotoxicity and its biochemical mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Estrogen-androgen hepatotoxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Quinine-induced hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Halothane hepatitis. Detection of a constitutional susceptibility factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. The Acute Liver Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatic failure in a patient taking rosiglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Rosiglitazone and hepatic failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Case Report: Fatal Fulminant Hepatic Failure due to Cyproterone Acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Ischemic hepatitis: clinical and laboratory observations of 34 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Acarbose-induced hepatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Glyburide-induced hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Free-radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Suspected cross-reactivity of enalapril- and captopril-induced hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Therapeutic misadventures with acetaminophen: Hepatoxicity after multiple doses in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Tetracycline-induced bile duct paucity and prolonged cholestasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Ticlopidine-induced cholestatic hepatitis: report of three cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxic effects of the anabolic/androgenic steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Drug-induced and toxic granulomatous hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Liver injury from cyclosporine A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Temporal variation in hepatotoxicity and metabolism of acetaminophen in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Quinidine-induced hepatitis. A common and reversible hypersensitivity reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Anticonvulsant hypersensitivity syndrome: incidence, prevention and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Prolonged cholestasis due to trimethoprim sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Cholestatic jaundice induced by ciprofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity of herbal remedies and mushrooms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Genetic predisposition to drug-induced hepatotoxicity

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

Terfenadine and hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Drug-induced hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Histopathologic analysis of suspected amiodarone hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Drug- and chemical-induced cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Enflurane hepatotoxicity. A clinicopathologic study of 24 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Acute liver failure after treatment with nefazodone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Pemoline hepatotoxicity in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

COX 2 inhibitor and fulminant hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Metabolism-dependent hepatotoxicity of methimazole in mice depleted of glutathione

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Severe hepatotoxicity associated with bromfenac sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Halothane-associated hepatitis in a 6-year-old boy: evidence for native liver regeneration following failed treatment with auxiliary liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Severe acetaminophen toxicity in a patient receiving isoniazid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Pemoline-associated hepatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Immune mechanisms in tienilic acid associated hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Tamoxifen-induced fatty liver in patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Paracetamol-induced acute liver failure: prevention and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Cirrhosis with steatohepatitis after adjuvant tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Liver damage from flucloxacillin, cloxacillin and dicloxacillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Felbamate in epilepsy therapy: evaluating the risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity associated with ritonavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

DRUG-INDUCED LIVER DISEASE: A PENALTY FOR PROGRESS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Antiandrogen hepatotoxicity in patients with chronic viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Fatal fulminant hepatitis associated with bromfenac use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Prescribing in liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Effects of liver disease on pharmacokinetics. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Epidemiology of hepatocellular adenoma. The role of oral contraceptive use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Transaminase elevation on placebo during phase I trials: prevalence and significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Terfenadine-induced cholestatic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Monitored Isoniazid Prophylaxis for Low-Risk Tuberculin Reactors Older Than 35 Years of Age: A Risk-Benefit and Cost-Effectiveness Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Rifampicin hepatitis. A clinical and histological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Etiology and outcome for 295 patients with acute liver failure in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Acetaminophen Toxicity in an Urban County Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Antiepileptic drug hypersensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Estrogen-Induced Cholestasis: Clues to Pathogenesis and Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Isoniazid-associated hepatitis deaths: a review of available information

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Predisposition to phenytoin hepatotoxicity assessed in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Minocycline and Lupuslike Syndrome in Acne Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Risperidone-induced hepatotoxicity in children and adolescents? A chart review study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Fatal cholestatic jaundice in elderly patients taking benoxaprofen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Review article: methotrexate in gastroenterology--dangerous villain or simply misunderstood?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Molecular pathogenesis of cholestasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Drug-induced vascular and sinusoidal lesions of the liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Treatment with aged garlic extract protects against bromobenzene toxicity to precision cut rat liver slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatic dysfunction associated with troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Chronic active hepatitis associated with etretinate therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

A prospective study of the causes of notably raised aspartate aminotransferase of liver origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Drug-Induced Vascular Lesions of the Liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Effects of aspirin and acetaminophen on the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Effects of alcohol on other hepatotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Ticrynafen-associated hepatic injury: analysis of 340 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

Liver function in postmenopausal women on estrogen-androgen hormone replacement therapy: a meta-analysis of eight clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

Immunoallergic drug-induced hepatitis: lessons from halothane

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

Propafenone-induced liver injury: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

Amoxicillin-clavulanate potassium-associated cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

Valproate-induced hepatic injury: analyses of 23 fatal cases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970287-X

7 January 2021

10.1016/S0025-7125(05)70287-X

Identifiers

DOI

1 reference

30 July 2017

1 reference